Treatment of axial spondyloarthritis patients with biologic disease-modifying anti-rheumatic drugs in 2022 - data from the Romanian Registry of Rheumatic Diseases

Objective. The objective of this cross-sectional study was to analyze data available in the Romanian Registry of Rheumatic Diseases (RRBR) in 2022 for axial spondyloarthritis (axSpA) patients treated with biologic disease modifying anti-rheumatic drugs (bDMARDs). Methods. From the RRBR electronic da...

Полное описание

Библиографические подробности

Главные авторы:	Laura Muntean, Razvan Ionescu, Corina Mogosan, Maria-Magdalena Tamas, Claudiu C. Popescu, Elena Rezus, Razvan-Constantin Ionitescu, Ana Maria Ramazan, Andrei Eugen Martin, Catalin Codreanu
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Amaltea Medical Publishing House 2023-12-01
Серии:	Romanian Journal of Rheumatology
Предметы:	axial spondyloarthritis biologics romanian registry of rheumatic diseases
Online-ссылка:	https://rjr.com.ro/articles/2023.4/RJR_2023_4_Art-04.pdf
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!